Zeta Surgical® AI-powered TMS Navigation System Receives FDA 510(k) Clearance

“This clearance classifies the system under product codes QFF and SGE—and, to our knowledge, marks the first TMS navigation device cleared under SGE,” said Hieu Le Mau, Chief Operating Officer at Zeta Surgical. “It provides a clear regulatory pathway for broader adoption.”
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain
The study is designed to compare genicular artery embolization (GAE) with Nexsphere-F™ to intra-articular corticosteroid injections, with the primary goal of assessing both safety and efficacy in patients with painful knee osteoarthritis. Nexsphere-F™ has already received multiple key U.S. regulatory designations, including FDA Breakthrough Device Designation, CMS IDE Category B approval, and participation in the TAP (Total Product Lifecycle Advisory Program).
How to Become a Better Nurse

If you are currently working in the field of nursing, then congratulations and well done! To say that nursing can be a challenging and difficult job is an understatement. This is because the job is usually one that is extremely fast-paced but also physically and mentally demanding. However, it is important to note that despite […]
Generative AI in Healthcare Set to Skyrocket with 33% CAGR Through 2032
The generative AI in healthcare market is set to grow from $1.8 billion in 2023, driving innovation and efficiency in the industry.
Monteris Medical and Symphony Robotics Announce Strategic Collaboration to Launch AI-Driven Micro-Robotic Platform for Laser Ablation in the Brain
Alliance aims to deliver breakthrough precision with laser ablation for
complex brain tumors and expand minimally invasive care
Asahi Kasei Elevates Critical Care Solutions with FDA Approval of ZOLL’s Zenix Monitor/Defibrillator

The Zenix monitor/defibrillator is designed for use in EMS and hospital settings
American Liver Foundation Hosts National Legacy Gala Honoring Leaders in Liver Health
For more information about ALF, visit www.liverfoundation.org. If you have any questions or concerns regarding liver disease, call the helpline at 1-800-Go-LIVER (800-465-4837) Monday through Friday from 9 a.m. to 5 p.m. ET.
Field Medical | First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025

The company will be featured across three sessions, including first-in-human six-month outcomes from its FieldForce™ Ablation System, the first focal contact-force PFA platform designed for VT, a pre-recorded live VT case and translational preclinical research
Summit Cancer Center Director, Arvind Chaudhry, MD, PhD, to Chair Coeur d’Alene Hematology Oncology Conference Focused on Precision-Guided Cancer Care
The conference, part of the nationally recognized Binaytara CME Conference Series, has become a cornerstone of regional medical education
Italfarmaco Appoints Francesco Di Marco as CEO
Dr. Di Marco brings over 25 years of experience in the biopharmaceutical industry through multiple executive leadership positions
Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia
Dario Eklund, Chief Executive Officer of Santhera, said: “This agreement will enable more children to access this important DMD treatment, and is the latest in a series of global agreements secured in 2025. We look forward to working closely with Biomedica in the months ahead.”
Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK
Planned UK trial to be led by Prof. Fiona Thistlethwaite at The Christie NHS Foundation Trust, a European hub for advanced therapies, with participation from Dr. Andrew Furness at The Royal Marsden, a world-renowned centre for oncology and early-phase clinical research